INNOVADERM CRO IS NOW INDERO.

Indero is attending the 2026 SID Annual Meeting in Chicago!

Author picture

Indero is pleased to announce its participation to the 2026 Society for Investigative Dermatology (SID) Annual Meeting, held May 13–16, 2026, at the Hilton Chicago. The event brings together global leaders in investigative dermatology for four days of cutting‑edge science, collaboration, and innovation.

As part of the adjacent Future Leaders Retreat on May 13, our Chief Medical and Scientific Officer will serve as Co‑Chair and present the session “Industrial Strength: Interactions and Partnerships with Industry,” contributing to a full day of guidance and career development for emerging dermatology investigators.

Indero representatives will be on site throughout the meeting, along with our exhibition booth. We look forward to engaging with industry’s top minds!

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.